期刊文献+

临床引发药品不良反应的主要品种分析及对策 被引量:1

下载PDF
导出
摘要 目的:讨论临床上引起不良反应药品的主要种类,提出相应对策,促进临床合理用药的发展。方法:有目的选取在本院接受治疗过程中出现过药物不良反应的病例303例,对相关资料进行统计分析,整理出引发药品不良反应的主要类别,分析其多发不良反应的原因,根据原因提出相应建议。结果:在303例中,因为抗感染药物引起的不良反应有98例,约占32.34%;因中药制剂引发不良反应的例数为85例,约占28.05%;其他药物比例均小于10%,排名依次为心脑血管类药物(9.91%)、解热镇痛类(8.25%)、神经系统类(6.27%)、抗肿瘤类(4.95%)、血液系统类药物(3.63%)。结论:临床上引发药品的不良反应的药物主要是抗感染类药物和中药制剂,这两种药物引发的不良反应的危害性也更加大。分析其不良反应多发性的原因,提出相应对策,对于提高用药安全性,减少不良反应的发生具有积极意义。所以,严格按照规定,合理使用药物,加强对质量标准的控制和安全用药知识的宣传,实现这一目标的必要措施。 Objective: to discuss the main types of adverse drug reactions in clinic, and put forward the corresponding countermeasures to promote the development of clinical rational drug use. Methods: to select in the hospital for treatment of adverse drug reactions occurred in 303 cases, statistical analysis of relevant data, sorting out the main categories lead to adverse drug reactions, analyzed the cause of multiple adverse reactions, according to the reasons put forward the corresponding suggestions. Results: in 303 cases, because of adverse reactions caused by anti infective drugs in 98 cases, accounted for 32.34%; the number of cases of adverse reactions caused by traditional Chinese medicine for 85 cases, accounting for about 28.05%; the proportion of other drugs were less than 10%, ranking of cardiovascular drugs(9.91%), antipyretic analgesics(8.25%) the nervous system type(6.27%), anti-tumor type(4.95%), hematological system drugs(3.63%). Conclusion: the adverse drug reactions induced by drugs are mainly anti infection drugs and traditional Chinese medicine preparations, the two kinds of drug induced adverse reactions are more dangerous. Analysis of the reasons for the adverse reactions of multiple causes, put forward the corresponding countermeasures, to improve the safety of medication, reduce the incidence of adverse reactions has a positive significance. Therefore, in strict accordance with the provisions of the rational use of drugs, to strengthen the quality control and safety knowledge of drug promotion, the necessary measures to achieve this goal.
出处 《中国妇幼健康研究》 2017年第S1期59-60,共2页 Chinese Journal of Woman and Child Health Research
关键词 临床用药 不良反应 种类分析 对策 clinical medication adverse reactions types of analysis Countermeasures
  • 相关文献

参考文献6

二级参考文献69

  • 1樊珍和.细菌的耐药性分析及其对策[J].中国医药指南,2008,6(20):127-128. 被引量:3
  • 2汤从容,张春红.静脉营养药所致不良反应的回顾性分析[J].浙江创伤外科,2006,11(5):458-459. 被引量:5
  • 3张冰,吴嘉瑞.关于中药注射剂安全性问题的思考[J].临床药物治疗杂志,2006,4(6):14-18. 被引量:112
  • 4孙忠实,朱珠.头孢曲松钠与钙剂配伍问题之释疑[J].中国医院用药评价与分析,2007,7(2):85-88. 被引量:42
  • 5克义,赵乃才.,临床药物不良反应大典[M].沈阳:辽宁科学技术出版社,2008:110.126.
  • 6Lu J, Cai C, Gu Y, et al. Analysis on 113 cases of adverse reactions caused by 13- Lactam antibiotics[J]. Afr J Tradit Complement Ahem Med,2013,10(4): 83 - 87.
  • 7Brismar B, Malmborg AS, Tunevall G, et al. Piperacillin - tazobactam ver- sus imipenem - eilastatin for treatment of intra - abdominal infections[J]. Antimicrob Agents Chemother, 1992,36(12): 2 766 -2 773.
  • 8Aronson JK, Ferner RE. Joining the Dots: new approach to classifying adverse drug reactions [ J ]. BMJ, 2003,327 (7 425 ) : 1 222 - 1 225.
  • 9Allred AJ, Bowen C J, Park JW, et al. Ehrombopag increases plasma rosuvastatin exposure in healthy volunteers [J]. Br J Clin Pharmaco, 2011, 172(2):321 - 329.
  • 10Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome 17450 2D6 (CYP2D6) genotype [J]. Clin Pharmacol Ther, 2012,91(2):321- 326.

共引文献21

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部